Dashboard
Manage Tickers

VRNAVerona Pharma plc

Nasdaq veronapharma.com


$ 14.46 $ -0.98 (-6.35 %)    

Friday, 28-Jun-2024 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 14.46
$ 15.12
$ 14.45 x 200
$ 14.47 x 200
$ 14.13 - $ 15.34
$ 11.39 - $ 23.07
2,154,366
na
9.34B
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-maintains-buy-on-verona-pharma-raises-price-target-to-38
Truist Securities Maintains Buy on Verona ...
06/28/2024 16:02:40

Truist Securities analyst Joon Lee maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price target from $32 to ...

first-inhaled-copd-therapy-in-over-2-decades---fda-approves-verona-pharmas-first-commercial-product
First Inhaled COPD Therapy In Over 2 Decad...
06/27/2024 13:49:19

The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary dis...

canaccord-genuity-maintains-buy-on-verona-pharma-maintains-35-price-target
Canaccord Genuity Maintains Buy on Verona ...
06/27/2024 13:45:19

Canaccord Genuity analyst Edward Nash maintains Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $35 price target.

hc-wainwright--co-maintains-buy-on-verona-pharma-raises-price-target-to-36
HC Wainwright & Co. Maintains Buy on Veron...
06/27/2024 10:24:27

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price tar...

trading-halt-halt-status-updated-at-52500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 5:25:...
06/26/2024 21:25:06

verona-pharma-says-fda-approved-ohtuvayre-ensifentrine-for-maintenance-treatment-of-chronic-obstructive-pulmonary-disease-in-adult-patients
Verona Pharma Says FDA Approved Ohtuvayre ...
06/26/2024 20:59:51

Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more...

trading-halt-halted-at-45721-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:57:21 p.m. ET - ...
06/26/2024 20:57:25

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

5-biotech-stocks-with-key-catalysts-this-week-merck-intellia-verona-and-more
5 Biotech Stocks With Key Catalysts This W...
06/24/2024 08:51:47

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

tesla-nvidia-john-wiley--sons-and-other-big-stocks-moving-higher-on-thursday
Tesla, Nvidia, John Wiley & Sons And Other...
06/13/2024 14:17:19

hc-wainwright--co-reiterates-buy-on-verona-pharma-maintains-32-price-target
HC Wainwright & Co. Reiterates Buy on Vero...
05/15/2024 10:01:00

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $32 price...

hc-wainwright--co-maintains-buy-on-verona-pharma-lowers-price-target-to-30
HC Wainwright & Co. Maintains Buy on Veron...
05/13/2024 14:54:08

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Verona Pharma (NASDAQ:VRNA) with a Buy and lowers the price tar...

verona-pharma-q1-2024-gaap-eps-004-beats-022-estimate
Verona Pharma Q1 2024 GAAP EPS $(0.04) Bea...
05/09/2024 11:19:09

verona-pharma-announces-650m-strategic-financing-with-oaktree-and-omers-cash-runway-extended-beyond-2026
Verona Pharma Announces $650M Strategic Fi...
05/09/2024 11:18:02

verona-pharma-to-present-additional-analyses-of-phase-3-enhance-studies-in-copd-at-ats-2024
Verona Pharma To Present Additional Analys...
05/02/2024 07:44:15

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine, an ...

piper-sandler-maintains-overweight-on-verona-pharma-raises-price-target-to-36
Piper Sandler Maintains Overweight on Vero...
04/16/2024 11:48:53

Piper Sandler analyst Yasmeen Rahimi maintains Verona Pharma (NASDAQ:VRNA) with a Overweight and raises the price target fro...

hc-wainwright--co-reiterates-buy-on-verona-pharma-maintains-32-price-target
HC Wainwright & Co. Reiterates Buy on Vero...
03/04/2024 12:09:38

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $32 price...

wedbush-reiterates-outperform-on-verona-pharma-maintains-33-price-target
Wedbush Reiterates Outperform on Verona Ph...
03/01/2024 13:37:02

Wedbush analyst Liana Moussatos reiterates Verona Pharma (NASDAQ:VRNA) with a Outperform and maintains $33 price target.

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

verona-pharma-q4-eps-002-flat-yoy-cash-balance-of-2718m
Verona Pharma Q4 EPS $(0.02), Flat YoY, Ca...
02/29/2024 07:04:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)